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In November 2018, yellow fever was diagnosed in a 
Dutch traveller returning from a bicycle tour in the 
Gambia-Senegal region. A complete genome sequence 
of yellow fever virus (YFV) from the case was gener-
ated and clustered phylogenetically with YFV from the 
Gambia and Senegal, ruling out importation into the 
Netherlands from recent outbreaks in Brazil or Angola. 
We emphasise the need for increased public aware-
ness of YFV vaccination before travelling to endemic 
countries.
We report the genomic sequence of yellow fever virus 
(YFV) genome directly from clinical samples from 
an unvaccinated Dutch traveller returning from the 
Gambia-Senegal region, where yellow fever (YF) is 
endemic. This report sends a reminder of the impor-
tance of vaccination for travellers to endemic areas and 
furthermore shares with the community a YFV genome 
sequence identified from an area with limited YFV 
sequence coverage.
Case description
The case was a healthy, unvaccinated adult in his mid-
20s who had travelled to the Gambia and Senegal 
for a 17-day bicycle tour in November 2018 (14 days 
in the Gambia and 3 days in Senegal). The patient 
had reported insect bites while travelling. During the 
returning flight to the Netherlands on 17 November, the 
patient developed fever and chills and then quickly pro-
gressed to acute kidney injury and fulminant liver fail-
ure for which he was hospitalised 20 November [1]. On 
21 November, the patient was referred to the Erasmus 
Medical Centre (Rotterdam, the Netherlands) for treat-
ment. Based on the clinical presentation and the recent 
travel history, YF was suspected and confirmed by a 
real-time PCR diagnostic assay on samples collected 
on 19 November and confirmed again on samples col-
lected on 21 November. The patient was discharged 3 
weeks after admission and has fully recovered from 
the infection. Full details of the clinical course and the 
advanced treatment will be described elsewhere.
Sample processing and agnostic deep 
sequencing
An in-house standard PCR for YFV yielded a Ct-value 
of 14 for a plasma sample collected on 19 November. 
This sample was prepared for whole genome sequenc-
ing as follows. Total nucleic acid was extracted using 
Roche MagNa Pure high performance extraction kit 
(Roche, Mannheim, Germany), followed by reverse 
transcription using random hexamer primers that avoid 
rRNA binding. Second strand synthesis was performed 
as previously described [2], followed by standard 
Ion Torrent library preparation as per manufacturer’s 
instruction. Deep sequencing was performed on the 
S5-XL sequencer, generating ca 10 million short reads 
of median length 263 nt. Short and low quality reads 
(< 75 nt, Phred score < 25) were removed and the remain-
ing reads were de novo assembled to larger contigs 
using SPAdes v.3.13.0 [3]. The YFV sequence contigs 
were identified using Usearch [4] against a set of viral 
family protein databases. A complete YFV genome 
(10771 nt) was obtained from the analysis.
Alignment and phylogenetic analysis
This YFV genome (GenBank accession number 
MK292067) and all available YFV genomes retrieved 
from GenBank (n=188) were aligned using MUSCLE [5], 
manually checked in AliView [6], and trimmed to the 
complete Open Reading Frame (ORF). The evolutionary 
model testing was implemented in IQ-TREE [7] using 
the Akaike Information Criterion (AIC).
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Figure 
Maximum-likelihood phylogenetic tree of the complete yellow fever virus genomes including sequence from Dutch traveller 
to the Gambia and Senegal in November 2018
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EAfr: East Africa genotype; SA1: South American I genotype; SA2: South American II genotype; WAfr: West Africa genotype; YVF: yellow fever 
virus.
Brazilian outbreak clade was indicated in dark blue (triangle). The reported YFV genome is indicated in red; the YFV vaccine strain is indicated 
in turquoise and the YFV strain from Angola outbreak is indicated in blue.
The genotypes of each YFV clade (as defined in [11]) are shown and abbreviated. The phylogeny was mid-point rooted for clarity and only 
bootstrap values for major clades were shown. The scale bar is shown in units of number of nt substitutions per site (subs/site).
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A maximum-likelihood phylogenetic tree was con-
structed using the sequence alignment in RAxML 
[8] under the GTR + Γ4  model of evolution, which was 
determined as the best-fitted model, bootstrapped 
with 100 pseudoreplicates. The resulting tree was vis-
ualised and edited in FigTree v1.4.2 (http://tree.bio.
ed.ac.uk/software/figtree/) and mid-point rooted for 
clarity.
Clustering with other YFV sequences
The reported YFV genome was found to belong to the 
West Africa genotype according to a genotyping tool 
(http://krisp.ukzn.ac.za/app/typingtool/yellowfevervi-
rus/) and in a maximum-likelihood phylogenetic tree 
(Figure). The reported genome was most closely related 
to a Gambian YFV genome from 2001 [9] with 98.3% 
nt identity across the entire genome and 195 nt differ-
ences and to Senegalese YFV genomes identified in 
2000 [10]. Earlier Senegalese YFV genomes from 1995, 
1996, 2001 and 2005 belonged to related but distinct 
lineages within the West Africa genotype. 
The viral sequence from the patient was clearly distinct 
from viral sequences from the recent large outbreaks 
in Brazil (SA1 lineage, Figure [11]) and Angola (EAfr line-
age, Figure [12]), suggesting that the YFV infection was 
likely a sylvatic case derived from locally circulating 
viruses in the Gambia and Senegal and not a new intro-
duction of the virus into this region. However, it should 
be noted that there is a paucity of publicly available 
YFV genome sequences from Africa.
Discussion and conclusion
YF is a severe, mosquito-borne flavivirus infection 
caused by YFV, that is estimated to result in 78,000 
deaths annually in Africa alone [13,14]. YFV transmission 
continues in tropical regions of the world with larger 
recent outbreaks reported in Brazil [11] and Angola. A 
smaller number of cases are reported from additional 
countries as listed on World Health Organization (WHO) 
news on disease outbreak [15]. Given the identification 
of co-circulating YFV lineages in regions over several 
years [9,11,15-22] and the general lack of sampling in 
the animal reservoir, it is plausible that more diversity 
may be observed with more comprehensive sequenc-
ing of newly diagnosed cases. Such surveillance in 
this part of the world would provide further knowledge 
and understanding of YFV transmission and evolution, 
which would be valuable in supporting the YF epidemic 
elimination initiative.
Although an effective and safe vaccine has been avail-
able since 1939 [23], vaccine coverage is still insuffi-
cient and a limited vaccine supply coupled with human 
population increases has led to high numbers of unvac-
cinated people living in endemic regions [24]. There 
have been several reports of YF cases in unvaccinated 
travellers returning from endemic regions in the past 
years such as to Belgium from the Gambia [9,16,18], 
to China from Angola [17,19] and to the Netherlands 
from Suriname [20,21] or from Brazil [22]. Furthermore, 
returning travellers may serve as sentinels for local 
outbreaks of pathogenic viruses that may have not yet 
been documented or adequately reported.
The WHO has launched a programme to eliminate YF 
epidemics in regions at risk for cases from enzootic 
circulation or new introductions [25]. A key component 
of a successful elimination campaign is the ability to 
detect new cases and to understand the ecology of YF 
in regions at risk. Whole genome viral sequences can 
provide important data for tracking viruses within and 
between outbreaks [11,26-28]. Having a rapid whole-
genome confirmation of a YFV infection and placing 
the sequence in the context of the global YFV phylo-
genetics is crucial for ruling out alternate transmission 
possibilities such as importation and introduction of 
YFV into the Netherlands from the recent large YFV out-
breaks in Brazil or Angola. This work also highlights 
the need to remain alert for unexpected infectious dis-
ease aetiologies in returning travellers and the need to 
consider vaccination before travelling to regions where 
YFV is endemic, even if the vaccination is not required 
by border control agencies or when there are no reports 
of human cases of YF in these regions.
Data availability
The YFV genomic sequence reported here is available 
on GenBank with the accession number MK292067.
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